Upper EXTremity Examination for Neuromuscular Diseases (U-EXTEND):Technology-enabled Methods to Assess Treatment Efficacy and Accelerate Drug Discovery
Spinal Muscular Atrophy (SMA) is a neurodegenerative disease of childhood and the leading genetic cause of death in infants. Duchenne Muscular Dystrophy is another progressive neuromuscular disease of childhood that leads to loss of motor movements, respiratory failure and death in young adulthood.The explosion of new potential treatments for these diseases presents the urgent need for more specific, more quantitative metrics that can be used to quickly and effectively evaluate the efficacy of any given treatment. This pilot study introduces a novel paradigm using concrete, quantitative measures to assess motor function in patients with SMA and DMD.
Publications
Robert Gutierrez, Allison McCrady, Chelsea Masterson, Sarah Tolman, Mehdi Boukhechba, Laura Barnes, Silvia Blemker, Rebecca Scharf. Upper Extremity Examination for Neuromuscular Diseases (U-EXTEND): Protocol for a Multimodal Feasibility Study. JMIR Research Protocols – Vol. 11, No. 10, October 2022
Shashwat Kumar, Robert Gutierezz, Debajyoti Datta, Sarah Tolman, Allison McCrady, Silvia Blemker, Rebecca J Scharf, Mehdi Boukhechba, Laura E Barnes. Shape Analysis for Pediatric Upper Body Motor Function Assessment. Proceedings of the 2022 ACM International Symposium on Wearable Computers – September 2022